Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0024554,
umls-concept:C0030685,
umls-concept:C0034493,
umls-concept:C0037659,
umls-concept:C0037663,
umls-concept:C0205227,
umls-concept:C0205263,
umls-concept:C0234421,
umls-concept:C0391871,
umls-concept:C0599861,
umls-concept:C0680255,
umls-concept:C1283071,
umls-concept:C1314939,
umls-concept:C1566942,
umls-concept:C1709059,
umls-concept:C1963578
|
pubmed:issue |
4
|
pubmed:dateCreated |
1984-5-8
|
pubmed:abstractText |
To clarify the role of noradrenergic neurons in the regulation of GH secretion, the effects of iv administered noradrenergic antagonists were investigated in freely moving, conscious male rabbits. During a 6-h observation period (1030-1630 h), control rabbits manifested pulsatile GH secretion with surges between 1030-1200 and 1415-1630 h. Phenoxybenzamine, (POB), an alpha-adrenergic blocker (5 mg/kg, twice), abolished the episodic GH surges; propranolol, a beta-adrenergic blocker (2.5 mg/kg, twice), did not. The bolus injection (1 or 10 micrograms) of synthetic human pancreatic GH-releasing factor (hpGHRF) with 44 amino acid residues (hpGHRF1-44) resulted in significant rises in the plasma GH of control animals. The plasma GH responses to hpGHRF1-44 were significantly larger in propranolol-treated than control rabbits. In contrast, POB completely suppressed the hpGHRF1-44-induced GH release. The injection of antisomatostatin (SRIF) serum into POB-treated rabbits did not yield a disinhibition of the episodic GH surges but restored the plasma GH rises after hpGHRF1-44 injection. These results indicate that noradrenaline++ plays an important role in regulating GH secretion in the rabbit. We propose that alpha-noradrenergic blockade suppresses GH release not only by inhibiting the release of hypothalamic GHRF but also by stimulating the secretion of SRIF and that beta-noradrenergic blockade enhances GH release by inhibiting the release of SRIF from the hypothalamus.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Growth Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Growth Hormone-Releasing Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Pancreatic Hormones,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Phenoxybenzamine,
http://linkedlifedata.com/resource/pubmed/chemical/Propranolol,
http://linkedlifedata.com/resource/pubmed/chemical/Somatostatin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0013-7227
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
114
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1402-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6142818-Animals,
pubmed-meshheading:6142818-Circadian Rhythm,
pubmed-meshheading:6142818-Consciousness,
pubmed-meshheading:6142818-Growth Hormone,
pubmed-meshheading:6142818-Growth Hormone-Releasing Hormone,
pubmed-meshheading:6142818-Humans,
pubmed-meshheading:6142818-Male,
pubmed-meshheading:6142818-Pancreas,
pubmed-meshheading:6142818-Pancreatic Hormones,
pubmed-meshheading:6142818-Peptide Fragments,
pubmed-meshheading:6142818-Phenoxybenzamine,
pubmed-meshheading:6142818-Propranolol,
pubmed-meshheading:6142818-Rabbits,
pubmed-meshheading:6142818-Radioimmunoassay,
pubmed-meshheading:6142818-Somatostatin
|
pubmed:year |
1984
|
pubmed:articleTitle |
Noradrenergic modulation of human pancreatic growth hormone-releasing factor (hpGHRF1-44)-induced growth hormone release in conscious male rabbits: involvement of endogenous somatostatin.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|